Limited data availability making it tough to assess omicron severity, says WHO

  • WHO says it needs more data to assess omicron mutations and its impact on vaccine efficacy

Sort of stating the obvious as this is the question that the world is waiting on at the moment. Vaccine makers are only likely to share some of their own findings in the next week or two. So, expect the WHO to trail behind that as per their standard operating procedure during the pandemic.

Go to top